Volume 173, Issue 1 pp. 272-274

Research Letter

Onset of psoriatic arthritis during ustekinumab treatment for psoriasis: a case series of seven patients

B.B. Jones,

B.B. Jones

School of Medicine, University of Utah, 30N 1900 East, Salt Lake City, UT, 84132 U.S.A

Search for more papers by this author

J.W. Millsop,

J.W. Millsop

University of California, Davis, Department of Dermatology, Sacramento, CA, U.S.A

Search for more papers by this author

J.A. Walsh,

J.A. Walsh

Division of Rheumatology, University of Utah, 30N 1900 East, Salt Lake City, UT, 84132 U.S.A

Search for more papers by this author

G.G. Krueger,

G.G. Krueger

Department of Dermatology, University of Utah, 30N 1900 East, Salt Lake City, UT, 84132 U.S.A

Search for more papers by this author

K. Callis Duffin,

Corresponding Author

K. Callis Duffin

Department of Dermatology, University of Utah, 30N 1900 East, Salt Lake City, UT, 84132 U.S.A

Correspondence: Kristina Callis Duffin.

E-mail: [email protected]

Search for more papers by this author

B.B. Jones,

B.B. Jones

School of Medicine, University of Utah, 30N 1900 East, Salt Lake City, UT, 84132 U.S.A

Search for more papers by this author

J.W. Millsop,

J.W. Millsop

University of California, Davis, Department of Dermatology, Sacramento, CA, U.S.A

Search for more papers by this author

J.A. Walsh,

J.A. Walsh

Division of Rheumatology, University of Utah, 30N 1900 East, Salt Lake City, UT, 84132 U.S.A

Search for more papers by this author

G.G. Krueger,

G.G. Krueger

Department of Dermatology, University of Utah, 30N 1900 East, Salt Lake City, UT, 84132 U.S.A

Search for more papers by this author

K. Callis Duffin,

Corresponding Author

K. Callis Duffin

Department of Dermatology, University of Utah, 30N 1900 East, Salt Lake City, UT, 84132 U.S.A

Correspondence: Kristina Callis Duffin.

E-mail: [email protected]

Search for more papers by this author

First published: 30 December 2014

https://doi.org/10.1111/bjd.13645

Citations: 24

Funding sources: None.

Conflicts of interest: K.C.D. has served on the scientific and marketing advisory boards of Amgen; served as a consultant to Amgen, Janssen, Pfizer and Eli Lilly receiving honoraria; received payments for lectures from AbbVie, Amgen and Janssen; and served as an investigator for AbbVie, Amgen, Janssen, Pfizer, Eli Lilly and Vascular Biologics Limited. G.G.K. has received fees as a consultant or advisory board member for AbbVie, Amgen, ApoPharma, Astellas, Boehringer Ingelheim, Bristol Myers Squibb, Eli Lilly, Idera, Isis, Janssen, L'Oréal, Novartis, Pfizer, UCB and Vascular Biologics Limited. G.G.K. has also received partial stipend support for a clinical research fellowship from AbbVie, Amgen and Centocor/Janssen, and in the last 12 months has received lecture fees from Abbott, Amgen and Janssen.

Share a link

Email
Wechat
Bluesky

References

1Schön MP, Boehncke WH. Psoriasis. N Engl J Med 2005; 352: 1899–912.
10.1056/NEJMra041320
CAS PubMed Web of Science® Google Scholar
2Mease PJ, Gladman DD, Papp KA et al. Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics. J Am Acad Dermatol 2013; 69: 729–35.
10.1016/j.jaad.2013.07.023
PubMed Web of Science® Google Scholar
3Kimball AB, Gordon KB, Fakharzadeh S et al. Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trial through up to 3 years. Br J Dermatol 2012; 166: 861–72.
10.1111/j.1365-2133.2012.10901.x
CAS PubMed Web of Science® Google Scholar
4Gottlieb A, Menter A, Mendelsohn A et al. Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomized, double-blind, placebo-controlled, crossover trial. Lancet 2009; 373: 633–40.
10.1016/S0140-6736(09)60140-9
CAS PubMed Web of Science® Google Scholar
5McInnes IB, Kavanaugh A, Gottlieb AB et al. Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial. Lancet 2013; 382: 780–9.
10.1016/S0140-6736(13)60594-2
CAS PubMed Web of Science® Google Scholar
6Stevenson ML, Markowitz O. Selection of therapies in patients with psoriasis and psoriatic arthritis. Psoriasis Forum 2011; 17: 144–7.
Google Scholar
7de Souza A, Ali-Shaw T, Reddy SM et al. Inflammatory arthritis following ustekinumab treatment for psoriasis: a report of two cases. Br J Dermatol 2013; 168: 210–12.
10.1111/j.1365-2133.2012.11206.x
CAS PubMed Web of Science® Google Scholar
8Stamell EF, Kutner A, Viola K, Cohen SR. Ustekinumab associated with flares of psoriatic arthritis. JAMA Dermatol 2013; 149: 1410–13.
10.1001/jamadermatol.2013.5728
PubMed Web of Science® Google Scholar
9Mease PJ, Goffe BS, Metz J et al. Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomized trial. Lancet 2000; 356: 385–90.
10.1016/S0140-6736(00)02530-7
CAS PubMed Web of Science® Google Scholar
10Kavanaugh A, Krueger GG, Beutler A et al. Infliximab maintains a high degree of clinical response in patients with active psoriatic arthritis through 1 year of treatment: results from the IMPACT 2 trial. Ann Rheum Dis 2007; 66: 498–505.
10.1136/ard.2006.058339
CAS PubMed Web of Science® Google Scholar
11Mease PJ, Ory P, Sharp JT et al. Adalimumab for long-term treatment of psoriatic arthritis: 2-year data from the Adalimumab Effectiveness in Psoriatic Arthritis Trial (ADEPT). Ann Rheum Dis 2009; 68: 702–9.
10.1136/ard.2008.092767
CAS PubMed Web of Science® Google Scholar
12de Gannes GC, Ghoreishi M, Pope J et al. Psoriasis and pustular dermatitis triggered by TNF-α inhibitors in patients with rheumatologic conditions. Arch Dermatol 2007; 143: 223–31.
10.1001/archderm.143.2.223
PubMed Web of Science® Google Scholar
13Jókai H, Szakonyi J, Kontár O et al. Impact of effective tumor necrosis factor-alfa inhibitor treatment on arterial intima-media thickness in psoriasis: results of a pilot study. J Am Acad Dermatol 2013; 69: 523–9.
10.1016/j.jaad.2013.06.019
CAS PubMed Web of Science® Google Scholar

Citing Literature

Volume173, Issue1

July 2015

Pages 272-274

Onset of psoriatic arthritis during ustekinumab treatment for psoriasis: a case series of seven patients

References

Citing Literature

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

Onset of psoriatic arthritis during ustekinumab treatment for psoriasis: a case series of seven patients

References

Citing Literature

References

Related

Information